NDRA
ENDRA Life Sciences Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$6.05
+6.51%Aug 17, 2026, 12:00 UTC
ENDRA Life Sciences Inc. reported its financial results for the second quarter ended June 30, 2026.
Source:Aug 17, 2026, 00:00 UTC
ENDRA Life Sciences Inc. completed a private placement raising gross proceeds of $50 million, with net proceeds of $3.8 million.
Jul 21, 2026, 22:05 UTC
ASP Isotopes proposed a merger with ENDRA Life Sciences.
Source:Jul 21, 2026, 22:05 UTC
ASP Isotopes plans to create a publicly listed helium and LNG platform through Noble Africa.
Source:Jun 25, 2026, 13:30 UTC
ASP Isotopes announces a proposed merger of Noble Africa with ENDRA Life Sciences, which would establish Noble Africa as a Nasdaq-listed helium platform for Renergen's Virginia Gas Project.